Literature DB >> 17415140

Clinical symptomatology and paranasal sinus involvement with nasal septal perforation.

Neil Bhattacharyya1.   

Abstract

OBJECTIVE: Determine the symptom manifestations, clinical impact, and incidence of chronic rhinosinusitis (CRS) in patients with newly diagnosed nasal septal perforation.
METHODS: A consecutive series of adult patients with nasal septal perforation were prospectively studied at the time of endoscopic diagnosis with the rhinosinusitis symptom inventory (RSI) and sinus computed tomography (CT). Patients' symptoms in the RSI symptom domains were computed. From the CT scan, septal perforation size and Lund scores were obtained. A separate (control) cohort of patients with CRS without septal perforation was matched to these patients for age, sex, and Lund score. RSI symptom domain comparisons were conducted between groups to determine the additional symptom burden conferred by septal perforation.
RESULTS: Thirty-three patients with septal perforation were enrolled (mean age, 48.2 yr; 69.7% female). Mean perforation size was 1.9 (SD, 2.1) cm. The mean Lund score was 5.8 (SD, 5.3); 16 (57.1%) patients met radiographic criteria for a concurrent diagnoses of CRS. Patients with septal perforation reported significant nasal and facial symptom domain scores (56.8 and 47.0, respectively [range, 0-100]). Oropharyngeal and systemic symptoms were less severe (29.7 and 34.7, respectively). However, after comparison with the matched control patients, no statistically significant differences were identified in sinonasal symptoms between patients with and without septal perforation (all P > .131).
CONCLUSIONS: Concurrent CRS may frequently accompany nasal septal perforation and may require appropriate treatment along with the perforation itself. The presence of septal perforation does not appear to significantly augment symptom severity in CRS.

Entities:  

Mesh:

Year:  2007        PMID: 17415140     DOI: 10.1097/01.mlg.0000256455.01473.72

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Nasal septum perforation and bevacizumab.

Authors:  Derek G Power; Nancy E Kemeny
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.738

2.  A CFD approach to understand nasoseptal perforations.

Authors:  M A Burgos; E Sanmiguel-Rojas; R Rodríguez; F Esteban-Ortega
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-24       Impact factor: 2.503

3.  Endoscopic measurement of nasal septum perforations.

Authors:  Jean-Claude Rosenthal; Eric L Wisotzky; Carsten Matuschek; Melanie Hobl; Anna Hilsmann; Peter Eisert; Florian C Uecker
Journal:  HNO       Date:  2021-10-11       Impact factor: 1.284

4.  Facial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis.

Authors:  Raphael Abegão de Camargo; Antonio C Nicodemo; Daniel Vaccaro Sumi; Eloisa Maria Mello Santiago Gebrim; Felipe Francisco Tuon; Lázaro Manoel de Camargo; Rui Imamura; Valdir Sabbaga Amato
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31

5.  [Endoscopic measurement of nasal septum perforations. German version].

Authors:  Jean-Claude Rosenthal; Eric L Wisotzky; Carsten Matuschek; Melanie Hobl; Anna Hilsmann; Peter Eisert; Florian C Uecker
Journal:  HNO       Date:  2021-09-03       Impact factor: 1.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.